These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 15722361

  • 1. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation.
    Kim MS, Day CJ, Morrison NA.
    J Biol Chem; 2005 Apr 22; 280(16):16163-9. PubMed ID: 15722361
    [Abstract] [Full Text] [Related]

  • 2. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS, Day CJ, Selinger CI, Magno CL, Stephens SR, Morrison NA.
    J Biol Chem; 2006 Jan 13; 281(2):1274-85. PubMed ID: 16280328
    [Abstract] [Full Text] [Related]

  • 3. Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES.
    Kim MS, Magno CL, Day CJ, Morrison NA.
    J Cell Biochem; 2006 Feb 15; 97(3):512-8. PubMed ID: 16211583
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.
    Biochem Biophys Res Commun; 2005 Apr 15; 329(3):839-45. PubMed ID: 15752732
    [Abstract] [Full Text] [Related]

  • 5. Gene array identification of osteoclast genes: differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte macrophage colony stimulating factor.
    Day CJ, Kim MS, Stephens SR, Simcock WE, Aitken CJ, Nicholson GC, Morrison NA.
    J Cell Biochem; 2004 Feb 01; 91(2):303-15. PubMed ID: 14743390
    [Abstract] [Full Text] [Related]

  • 6. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
    Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, Kukita T, Yoshioka K, Rao A, Yoneda T.
    J Clin Invest; 2004 Aug 01; 114(4):475-84. PubMed ID: 15314684
    [Abstract] [Full Text] [Related]

  • 7. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
    Hounoki H, Sugiyama E, Mohamed SG, Shinoda K, Taki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Miyahara T.
    Bone; 2008 Apr 01; 42(4):765-74. PubMed ID: 18242157
    [Abstract] [Full Text] [Related]

  • 8. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes.
    Shinoda K, Sugiyama E, Taki H, Harada S, Mino T, Maruyama M, Kobayashi M.
    Bone; 2003 Oct 01; 33(4):711-20. PubMed ID: 14555277
    [Abstract] [Full Text] [Related]

  • 9. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug 01; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B.
    Cappellen D, Luong-Nguyen NH, Bongiovanni S, Grenet O, Wanke C, Susa M.
    J Biol Chem; 2002 Jun 14; 277(24):21971-82. PubMed ID: 11923298
    [Abstract] [Full Text] [Related]

  • 11. Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration.
    Kwak HB, Lee SW, Jin HM, Ha H, Lee SH, Takeshita S, Tanaka S, Kim HM, Kim HH, Lee ZH.
    Blood; 2005 Apr 01; 105(7):2963-9. PubMed ID: 15585657
    [Abstract] [Full Text] [Related]

  • 12. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P, Tu Q, Chen J.
    J Bone Miner Res; 2005 Sep 01; 20(9):1669-79. PubMed ID: 16059638
    [Abstract] [Full Text] [Related]

  • 13. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.
    Bone; 1999 Nov 01; 25(5):517-23. PubMed ID: 10574571
    [Abstract] [Full Text] [Related]

  • 14. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D, Lukić IK, Kovacić N, Ivcević S, Katavić V, Marusić A.
    Clin Exp Immunol; 2006 Oct 01; 146(1):146-58. PubMed ID: 16968409
    [Abstract] [Full Text] [Related]

  • 15. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N.
    Endocrinology; 2001 Aug 01; 142(8):3656-62. PubMed ID: 11459815
    [Abstract] [Full Text] [Related]

  • 16. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF.
    J Bone Miner Res; 2002 Jul 01; 17(7):1200-10. PubMed ID: 12096833
    [Abstract] [Full Text] [Related]

  • 17. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X, Huang Y, Collin-Osdoby P, Osdoby P.
    J Bone Miner Res; 2004 Dec 01; 19(12):2065-77. PubMed ID: 15537451
    [Abstract] [Full Text] [Related]

  • 18. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May 01; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 19. Annexin II stimulates RANKL expression through MAPK.
    Li F, Chung H, Reddy SV, Lu G, Kurihara N, Zhao AZ, Roodman GD.
    J Bone Miner Res; 2005 Jul 01; 20(7):1161-7. PubMed ID: 15940368
    [Abstract] [Full Text] [Related]

  • 20. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL.
    Tsujisawa T, Inoue H, Nishihara T.
    J Bone Miner Res; 2005 Jan 01; 20(1):15-22. PubMed ID: 15619665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.